Pil Pharmaceuticals Limited was incorporated in 2007 by its present Managing Director & CEO, Mr. Navdeep Chawla, a visionary and with a rich experience of having worked with various multinational companies. The Company has one state of the art WHO GMP compliant manufacturing facilities and a dominant market reach is all a result of dedication and commitment of the PIL team.

Mr. Siddharth Chawla, a management graduate from Edinburgh Scotland (U.K.) also joined the company in 2007 as Director Operations and has further enhanced the growth of the company by leading a team of highly motivated professionals, marketing as well as in the manufacturing and exports.

The Company operates under the umbrella of PIL Group, with a reach across PAN India and Overseas. The Company has exclusivity in Beta-lactam formulations for the PIL Brand.

Our state of the art manufacturing facilities have been set up in a total land area of (2000 square meters) at Haridwar in North India.

Pil Pharmaceuticals Limited manufactures a wide range of products in separate blocks constructed and being maintained as per WHO GMP guidelines. High speed automatic machines have been installed at each manufacturing facilities from top brand manufactures in India. The strict implementation of EHS meets the requirements of safety, effectiveness & environment concerns.